切换导航
  • 比较产品
我的购物车

若您需要咨询产品或有任何技术问题，请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系

StemSpan™髓系扩增补品（100X）

人粒细胞扩增和分化的无血清培养补充物
率先评论此产品
添加并比较

产品号 #（选择产品）

产品号 #02693_C

人粒细胞扩增和分化的无血清培养补充物

产品优势

  • 在14天的液体培养中，促进每个输入CD34+人CB细胞产生数千个CD15+粒细胞。
  • 作为100X浓缩物供应。在解冻和混合后，试管内容物可以直接添加到任何选择的造血细胞扩增培养基中。
main product photo
总览
实验数据
产品说明书及文档
应用领域
相关材料与文献
相关产品

总览

StemSpan™髓系扩增补充（100X）含有重组人细胞因子的组合，用于选择性地促进人髓系祖细胞的扩增和分化，从人脐带血（CB）或骨髓（BM）样本中分离的CD34+细胞产生大量CD15+粒细胞。

StemSpan™髓系扩增补剂可与以下任何StemSpan™培养基结合使用：
•StemSpan™SFEM（目录#09600）
StemSpan™SFEM II（目录#09605）
StemSpan™-XF（目录#100-0073）
StemSpan™-AOF（目录#100-0130）

当添加到无血清培养基中时，StemSpan™髓系扩增补充剂通常促进每个输入CD34+细胞在CD34+人CB细胞启动的14天液体培养中产生数千个CD15+粒细胞。请参阅data选项卡了解更多详细信息。

Contains
• Recombinant human stem cell factor (SCF)
• Recombinant human thrombopoietin (TPO)
• Recombinant human granulocyte colony-stimulating factor (G-CSF)
• Recombinant human granulocyte/macrophage colony-stimulating factor (GM-CSF)
 
Subtype
Supplements
 
Cell Type
Hematopoietic Stem and Progenitor Cells, Myeloid Cells
 
Species
Human
 
Application
Cell Culture, Differentiation, Expansion
 
Brand
StemSpan
 
Area of Interest
Stem Cell Biology, Transplantation Research
 
Formulation Category
Serum-Free
 

查看更多 显示更少

实验数据

Production of CD13+ and CD15+ Myeloid Cells by the Expansion and Lineage-Specific Differentiation of Human BM-Derived Cells Cultured in StemSpan™ SFEM II Containing Myeloid CD34+ Expansion Supplement

Figure 1. Production of CD13+ and CD15+ Myeloid Cells by the Expansion and Lineage-Specific Differentiation of Human BM-Derived Cells Cultured in StemSpan™ SFEM II Containing Myeloid Expansion Supplement

Flow cytometry dot plots for 14-day cultures of human BM-derived CD34+ cells in StemSpan™ SFEM II containing Myeloid Expansion Supplement showing expression of the HSPC marker CD34, and pan-hematopoietic marker CD45 (A) before and (B) after 14 days of culture, and expression of myeloid markers CD13 and CD15 (C) after 14 days of culture. The frequency of CD34+ cells declined from 83% before culture to ~1% after 14 days. In parallel, myeloid CD13+CD15+ cells gradually accumulated from <10% on day 0 to 46% by day 14. The frequency of CD14+ cells after culture was low (typically <10%, see Table 1).

Table 1. Production of Myeloid Cells from Human CB-Derived CD34+ Cells Cultured in StemSpan™ SFEM II Containing Myeloid Expansion Supplement

Production of Myeloid Cells from Human CB-Derived CD34+ Cells Cultured in StemSpan™ SFEM II Containing Myeloid Expansion Supplement

Number of total nucleated cells (TNCs) produced per input human CB-derived CD34+ cell from 14 different donors and percentage of cells positive for myeloid markers CD13, CD14 and CD15 produced after 14 days of culture in SFEM II containing Myeloid Expansion Supplement. Best expansion was obtained in SFEM II, but myeloid cell expansion may also be obtained in SFEM and ACF media.
*95% confidence limits (CL), the range within which 95% of the results will typically fall.

产品说明书及文档

请在《产品说明书》中查找相关支持信息和使用说明，或浏览下方更多实验方案。

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Information Sheet
Product Name
StemSpan™ Myeloid Expansion Supplement (100X)
Catalog #
02693
Lot #
All
Language
English
Document Type
Safety Data Sheet
Product Name
StemSpan™ Myeloid Expansion Supplement (100X)
Catalog #
02693
Lot #
All
Language
English

应用领域

本产品专为以下研究领域设计，适用于工作流程中的高亮阶段。探索这些工作流程，了解更多我们为各研究领域提供的其他配套产品。

Research Area
Workflow Stages

更多信息

更多信息
种属 Human
Contains • Recombinant human stem cell factor (SCF) • Recombinant human thrombopoietin (TPO) • Recombinant human granulocyte colony-stimulating factor (G-CSF) • Recombinant human granulocyte/macrophage colony-stimulating factor (GM-CSF)
配方类别 Serum-Free
质量保证:

产品仅供研究使用，不用于针对人或动物的诊断或治疗。 欲获悉更多关于STEMCELL的质控信息，请访问 STEMCELL.CN/COMPLIANCE.
Copyright © 2025 by STEMCELL Technologies. All rights reserved.